Grenada
Tuberculosis profile
Population  2012 <1 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 0.99 (0.95–1)
Mortality (HIV+TB only) <0.01 (0–<0.01) 0.13 (0–1.2)
Prevalence  (includes HIV+TB) <0.01 (<0.01–0.015) 6.8 (2.1–14)
Incidence  (includes HIV+TB) <0.01 (<0.01–<0.01) 4.1 (3.4–4.9)
Incidence (HIV+TB only) <0.01 (0–<0.01) 0.46 (0–3)
Case detection, all forms (%) 23 (19–28)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 1 (100) Relapse 0  
Smear-negative 0 (0) Treatment after failure 0  
Smear-unknown / not done 0 (0) Treatment after default 0  
Extrapulmonary 0 (0) Other 0  
Other 0 (0)      
Total new 1   Total retreatment 0  
           
Other (history unknown) 0        
Total new and relapse 1   Total cases notified 1  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio      
Age < 15      
Laboratories 2012
Is second-line drug susceptibility testing available? No
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 100   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 100  
Retreatment    
TB/HIV 2012 Number (%)
TB patients with known HIV status 1 (100)
HIV-positive TB patients 0 (0)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB 8  
HIV-positive people provided with IPT 0  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.2 (1.4–3.1) 14 (4.6–23)
MDR-TB cases among notified pulmonary
TB cases
0 (0–0) 0 (0–0)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB      
Laboratory-confirmed MDR-TB cases     0
Patients started on MDR-TB treatment     0
Financing TB control 2013
National TB programme budget (US$ millions) <1
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-17 Data: www.who.int/tb/data